Pharma
Astoriom expands global footprint for sample stability storage services
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions ...
Closed Loop Medicine appoints Kate Woolland as CEO
Leadership transition to drive commercialization strategy in deploying and scaling proven platform and therapy-specific precision dosing technologies ...
Cooling for Aesthetic Laser Systems: Meeting Huge Demands with Compact Solutions
Small and compact laser systems have become a staple of the growing aesthetics market – mostly for skin treatments like hair removal. To offer a well-balanced system, manufacturers must balance several conflicting factors. This results in high demands towards the system components. ...
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion ...
Shift Bioscience appoints Lord David Prior and Sir Tony Kouzarides to support long-term strategy for cell rejuvenation therapeutics
Lord David Prior appointed as Chair of the Board, previously Chairman of NHS England and member of the UK Life Sciences Council Sir Tony Kouzarides, Co-founder and Director, Milner Therapeutics Institute, and Professor of Cancer Biology, Gurdon Institute, appointed as Scientific Advisor...
Maintaining balance in the immune system: exploring the role of RNA binding proteins in regulatory T cell function
Researchers from the Turner lab at the Babraham Institute have published the first description of the role of the ZFP36 family of RNA binding proteins in regulatory T cells (Tregs). ...
Webinar - Lead Optimization: A collaborative workflow for computational and medicinal chemists using Cresset solutions
In the latest Flare™ V10 webinar, we showcase a lead optimization workflow, utilizing Cresset in silico solutions. Here we will demonstrate a process of first reviewing ideas in collaboration with colleagues to aid the identification of interesting molecules, followed by further investi...
Exploring treatment options for ILD
Interstitial lung disease (ILD) refers to a group of lung disorders that cause inflammation and scarring of lung tissue, leading to progressive breathing difficulties. While there is currently no cure for ILD, treatment focuses on controlling symptoms, slowing disease progression, and i...
ELRIG announces keynote speakers for Drug Discovery 2025
Prof Heather Pinkett and Dr Dafydd Owen to lead ELRIG’s flagship event Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate “A Festival of Life Science”Event supported by VisitBritain showcases UK life science sector and extends international reachCambridge, UK, 07 May 2...
Drug Discovery 2025
ELRIG’s Drug Discovery is again hosted by the city of Liverpool and as Europe’s leading Drug Discovery and Life Sciences conference will have scientific tracks covering topics such as Translating ideas into Therapies, Chemical Biology and Omics as well as Advanced Models for Drug Discov...